DE eng

Search in the Catalogues and Directories

Hits 1 – 6 of 6

1
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
BASE
Show details
2
Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2005)
BASE
Show details
3
Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits
In: American Journal of Human Genetics , 76 (6) pp. 1074-1080. (2005) (2005)
BASE
Show details
4
Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits
In: AM J HUM GENET , 76 (6) 1074 - 1080. (2005) (2005)
BASE
Show details
5
Identification of FOXP2 Truncation as a novel cause of developmental speech and language deficits
In: American Journal of Human Genetics , 76 (6) pp.1074 - 1080. (2005) (2005)
BASE
Show details
6
40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.
Veitenhansl M, Stegner K; Chatellier G, Group D.E.S.I.R.; DIABHYCAR Study Group, Nichols GA. - : Springer, 2004. : country:DEU, 2004. : place:Berli, 2004
BASE
Show details

Catalogues
0
0
0
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
6
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern